tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

INSM Stock Latest News

Insmed price target raised to $231 from $223 at TD Cowen
The FlyInsmed price target raised to $231 from $223 at TD Cowen
5h ago
INSM
Insmed’s Brinsupri Approval and Strategic Market Expansion Justify Buy Rating
PremiumRatings
Insmed’s Brinsupri Approval and Strategic Market Expansion Justify Buy Rating
19h ago
INSM
Insmed’s BRINSUPRI Approved by European Commission
PremiumCompany Announcements
Insmed’s BRINSUPRI Approved by European Commission
2d ago
8K
INSM
Insmed’s Brinsupri approved in EU for non-cystic fibrosis bronchiectasis
PremiumThe Fly
Insmed’s Brinsupri approved in EU for non-cystic fibrosis bronchiectasis
2d ago
INSM
Insmed price target raised to $225 from $196 at Goldman Sachs
PremiumThe Fly
Insmed price target raised to $225 from $196 at Goldman Sachs
17d ago
INSM
Insmed price target raised to $214 from $139 at Truist
PremiumThe FlyInsmed price target raised to $214 from $139 at Truist
18d ago
INSM
Insmed’s Earnings Call: Achievements and Caution
Premium
Company Announcements
Insmed’s Earnings Call: Achievements and Caution
20d ago
INSM
BofA boosts Insmed price target, says one of the stronger stories in the space
Premium
The Fly
BofA boosts Insmed price target, says one of the stronger stories in the space
20d ago
INSM
Insmed price target raised to $215 from $139 at RBC Capital
PremiumThe Fly
Insmed price target raised to $215 from $139 at RBC Capital
20d ago
INSM
Insmed price target raised to $223 from $194 at UBS
PremiumThe Fly
Insmed price target raised to $223 from $194 at UBS
20d ago
INSM
Strong Buy Rating for Insmed Driven by Brinsupri’s Success and Promising Pipeline
PremiumRatings
Strong Buy Rating for Insmed Driven by Brinsupri’s Success and Promising Pipeline
20d ago
INSM
Insmed price target raised to $217 from $171 at Wells Fargo
PremiumThe Fly
Insmed price target raised to $217 from $171 at Wells Fargo
20d ago
INSM
Insmed’s Q3 2025 Earnings Highlight Growth and Expansion
PremiumCompany AnnouncementsInsmed’s Q3 2025 Earnings Highlight Growth and Expansion
21d ago
INSM
Strong Financial Performance and Promising Pipeline Drive Buy Rating for Insmed
Premium
Ratings
Strong Financial Performance and Promising Pipeline Drive Buy Rating for Insmed
21d ago
INSM
Insmed’s Strong Financial Performance and Promising Product Launches Reinforce Buy Rating
Premium
Ratings
Insmed’s Strong Financial Performance and Promising Product Launches Reinforce Buy Rating
21d ago
INSM
Insmed raises 2025 global Arikayce revenue view to $420M-$430M from $405M-$425M
PremiumThe Fly
Insmed raises 2025 global Arikayce revenue view to $420M-$430M from $405M-$425M
21d ago
INSM
Insmed reports Q3 EPS ($1.75), consensus ($1.37)
PremiumThe Fly
Insmed reports Q3 EPS ($1.75), consensus ($1.37)
21d ago
INSM
Insmed price target raised to $196 from $165 at Mizuho
PremiumThe Fly
Insmed price target raised to $196 from $165 at Mizuho
22d ago
INSM
Insmed assumed with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Insmed assumed with an Overweight at Cantor Fitzgerald
23d ago
INSM
INSM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsINSM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
23d ago
INSM
Insmed’s CEDAR Study: A Potential Game-Changer for Hidradenitis Suppurativa Treatment
Premium
Company Announcements
Insmed’s CEDAR Study: A Potential Game-Changer for Hidradenitis Suppurativa Treatment
24d ago
INSM
Insmed’s Phase 1 Study on TPIP Formulations: A Potential Game-Changer in Drug Delivery
Premium
Company Announcements
Insmed’s Phase 1 Study on TPIP Formulations: A Potential Game-Changer in Drug Delivery
24d ago
INSM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >